Table I.
Baseline clinical data of the study group
| Parameter | All patients (n = 214) | Symptomatic patients (n = 121) (57%) | Asymptomatic patients (n = 93) (43%) |
|---|---|---|---|
| Age, mean ± SD [years] | 68 ±9 | 67 ±9 | 69 ±9 |
| Age – older (> 75 years), n (%) | 53 (25) | 22 (18) | 31 (33) |
| Sex – female, n (%) | 70 (33) | 38 (31) | 32 (34) |
| DM, n (%) | 77 (36) | 37 (31) | 40 (43) |
| Dyslipidaemia, n (%) | 99 (46) | 55 (45) | 44 (47) |
| CAD, n (%) | 156 (73) | 74 (61) | 82 (88)*** |
| Previous ACS, n (%) | 103 (48) | 49 (41) | 54 (58)* |
| Previous PCI or CABG, n (%) | 129 (60) | 63 (52) | 66 (71)* |
| Heart failure, n (%) | 58 (27) | 29 (24) | 29 (31) |
| Peripheral artery disease, n (%) | 42 (20) | 27 (22) | 15 (16) |
| Previous (> 6 months) stroke and/or TIA, n (%) | 68 (32) | 61 (50)*** | 7 (8) |
| Hypertension, n (%) | 175 (82) | 102 (84) | 73 (78) |
| CKD, n (%) | 33 (16) | 20 (17) | 14 (15) |
| Active smokers, n (%) | 30 (14) | 13 (11) | 17 (18) |
Data are presented as numbers and percentages for categorical variables. Quantitative values with normal distribution are shown as mean ± standard deviation.
*
p < 0.05
***
p < 0.001.
DM – diabetes mellitus, CAD – coronary artery disease, ACS – acute coronary syndrome, TIA – transient ischaemic attack, CKD – chronic kidney disease, PCI – percutaneous coronary intervention, CABG – coronary artery bypass graft